Malabsorption is a digestive disorder in which the small intestine fails to absorb essential nutrients such as carbohydrates, proteins, fat, vitamins and minerals from food. This condition leads to nutritional deficiencies, weight loss, weakness and other health issues. This may result in various gastrointestinal diseases, infections or deficiencies of enzymes.
It occurs when the body cannot digest or absorb carbohydrates, causing inflammation, diarrhea and stomach problems after consumption of carbohydrates.
It occurs when proteins do not break or are not absorbed adequately, which gives muscle ruin, weakness, inflammation and nutritional deficiencies.
Results from impaired digestion or absorption of dietary fats, leading to greasy stools, weight loss, and essential fatty acid deficiencies.
The inability to absorb essential vitamins and minerals causes fatigue, anemia, bone weakness and impaired immune system functioning.
There are frequent, loose, water stool due to improper digestion and absorption of nutrients.
Significant weight reduction happens because the body fails to absorb essential nutrients from food.
Inflammation and inflammation of the stomach is caused by gas accumulation from uninterrupted food.
Deficiency of vitamins, minerals, and proteins leads to fatigue, weakness, and other health problems.
Passage of pale, greasy, foul-smelling stools results from improper fat absorption in the intestines.
Measuring electrolytes, albumin, and total protein levels helps detect nutrient deficiencies caused by malabsorption. Low protein levels may indicate poor protein absorption. Electrolyte imbalances can lead to dehydration, weakness, or cardiac issues. These tests help assess the severity and systemic effects of malabsorption on the body.
Stool tests detect fat, blood, and inflammatory markers such as calprotectin or lactoferrin. Presence of fat in stool (steatorrhea) confirms fat malabsorption. These tests also help rule out infections or other gastrointestinal disorders. Stool analysis is a non-invasive, first-line investigation in patients with malabsorption symptoms.
This test quantifies fat content in stool over 24–72 hours. Excess fat indicates fat malabsorption. It helps identify pancreatic insufficiency, bile acid deficiency, or small intestine disorders. The fecal fat test is especially useful in confirming the cause of greasy, bulky stools and guiding further treatment.
Blood tests for vitamins A, D, E, K, B12, folate, and minerals like iron and calcium determine specific deficiencies. Detecting these deficiencies helps guide supplementation and treatment. Abnormal levels indicate impaired absorption and can explain clinical manifestations such as anemia, bone weakness, or neurological symptoms.
Upper or lower gastrointestinal endoscopy allows direct visualization of the intestinal lining. Biopsy samples from the small intestine can detect celiac disease, Crohn’s disease, or other structural abnormalities. Histopathology confirms the diagnosis and helps differentiate between different causes of malabsorption, guiding appropriate management and therapy.
Imaging techniques like CT enterography or MRI provide detailed views of the small intestine. They detect structural abnormalities, inflammation, strictures, or tumors causing malabsorption. Imaging helps evaluate the extent of disease involvement and can guide further diagnostic procedures or surgical planning if required.
Used to detect carbohydrate malabsorption, especially lactose or fructose intolerance. Undigested carbohydrates are fermented by intestinal bacteria, producing hydrogen detected in breath samples. This non-invasive test helps identify specific malabsorption causes and guides dietary modifications to manage symptoms and prevent further nutritional deficiencies.
Tests like fecal elastase or serum pancreatic enzyme levels evaluate pancreatic insufficiency. Reduced enzyme production affects protein, fat, and carbohydrate digestion, leading to malabsorption. Identifying pancreatic dysfunction is essential for proper enzyme replacement therapy and symptom management in patients with chronic pancreatitis or other pancreatic disorders.
Blood tests for anti-tissue transglutaminase (tTG) and anti-endomysial antibodies detect celiac disease. Positive results indicate an autoimmune response causing intestinal damage and malabsorption. These tests help confirm celiac disease before or along with biopsy, guiding dietary treatment with gluten restriction to restore nutrient absorption and health.
Copyright © 2025 – Designed by Camsol Advertising